1)Vermaelen K, Pauwels R. Accurate and simple discrimination of mouse pulmonary dendritic cell and macrophage populations by flow cytometry: methodology and new insights. Cytometry A. 2004; 61: 170-7
|
|
|
2)Cleret A, Quesnel-Hellmann A, Mathieu J, et al. Resident CD11c+ lung cells are impaired by anthrax toxins after spore infection. J Infect Dis. 2006; 194: 86-94
|
|
|
3)Duan M, Li WC, Vlahos R, et al. Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease. J Immunol. 2012; 189: 946-55
|
|
|
4)von Garnier C, Filgueira L, Wikstrom M, et al. Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract. J Immunol. 2005; 175: 1609-18
|
|
|
5)Grundy M, Sentman CL. GFP transgenic mice show dynamics of lung macrophages. Exp Cell Res. 2005; 310: 409-16
|
|
|
6)Gonzalez-Juarrero M, Shim TS, Kipnis A, et al. Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J Immunol. 2003; 171: 3128-35
|
|
|
7)Albert RK, Embree LJ, McFeely JE, et al. Expression and function of beta 2 integrins on alveolar macrophages from human and nonhuman primates. Am J Respir Cell Mol Biol. 1992; 7: 182-9
|
|
|
8)Guth AM, Janssen WJ, Bosio CM, et al. Lung environment determines unique phenotype of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2009; 296: L936-46
|
|
|
9)Geissmann F, Gordon S, Hume DA, et al. Unravelling mononuclear phagocyte heterogeneity. Nat Rev Immunol. 2010; 10: 453-60
|
|
|
10)Hume DA. Macrophages as APC and the dendritic cell myth. J Immunol. 2008; 181: 5829-35
|
|
|
11)Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010; 32: 593-604
|
|
|
12)Kumagai Y, Takeuchi O, Kato H, et al. Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity. 2007; 27: 240-52
|
|
|
13)Maus UA, Janzen S, Wall G, et al. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol. 2006; 35: 227-35
|
|
|
14)Landsman L, Jung S. Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J Immunol. 2007; 179: 3488-94
|
|
|
15)Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005; 5: 953-64
|
|
|
16)Jenkins SJ, Ruckerl D, Cook PC, et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science. 2011; 332: 1284-8
|
|
|
17)Golde DW, Byers LA, Finley TN. Proliferative capacity of human alveolar macrophage. Nature. 1974; 247: 373-5
|
|
|
18)Bitterman PB, Saltzman LE, Adelberg S, et al. Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J Clin Invest. 1984; 74: 460-9
|
|
|
19)Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003; 19: 71-82
|
|
|
20)Landsman L, Varol C, Jung S. Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol. 2007; 178: 2000-7
|
|
|
21)Srivastava M, Jung S, Wilhelm J, et al. The inflammatory versus constitutive trafficking of mononuclear phagocytes into the alveolar space of mice is associated with drastic changes in their gene expression profiles. J Immunol. 2005; 175: 1884-93
|
|
|
22)Xiong Z, Leme AS, Ray P, et al. CX3CR1+ lung mononuclear phagocytes spatially confined to the interstitium produce TNF-alpha and IL-6 and promote cigarette smoke-induced emphysema. J Immunol. 2011; 186: 3206-14
|
|
|
23)Lagranderie M, Nahori MA, Balazuc AM, et al. Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production. Immunology. 2003; 108: 352-64
|
|
|
24)Kim TS, Braciale TJ. Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS One. 2009; 4: e4204
|
|
|
25)Breel M, Van der Ende M, Sminia T, et al. Subpopulations of lymphoid and non-lymphoid cells in bronchus-associated lymphoid tissue (BALT) of the mouse. Immunology. 1988; 63: 657-62
|
|
|
26)Tailleux L, Pham-Thi N, Bergeron-Lafaurie A, et al. DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis. PLoS Med. 2005; 2: e381
|
|
|
27)Edwards JP, Zhang X, Frauwirth KA, et al. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol. 2006; 80: 1298-307
|
|
|
28)Lin KL, Suzuki Y, Nakano H, et al. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol. 2008; 180: 2562-72
|
|
|
29)Sung SS, Fu SM, Rose CE, Jr, et al. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol. 2006; 176: 2161-72
|
|
|
30)Johnston LK, Rims CR, Gill SE, et al. Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury. Am J Respir Cell Mol Biol. 2012; 47: 417-26
|
|
|
31)Janssen WJ, Barthel L, Muldrow A, et al. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am J Respir Crit Care Med. 2011; 184: 547-60
|
|
|
32)Rosseau S, Hammerl P, Maus U, et al. Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2000; 279: L25-35
|
|
|
33)Dawson TC, Beck MA, Kuziel WA, et al. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol. 2000; 156: 1951-9
|
|
|
34)Herold S, von Wulffen W, Steinmueller M, et al. Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J Immunol. 2006; 177: 1817-24
|
|
|
35)Maus U, von Grote K, Kuziel WA, et al. The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. Am J Respir Crit Care Med. 2002; 166: 268-73
|
|
|
36)Herold S, Tabar TS, Janssen H, et al. Exudate macrophages attenuate lung injury by the release of IL-1 receptor antagonist in gram-negative pneumonia. Am J Respir Crit Care Med. 2011; 183: 1380-90
|
|
|
37)Egawa M, Mukai K, Yoshikawa S, et al. Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Immunity. 2013; 38: 570-80
|
|
|
38)Bem RA, Farnand AW, Wong V, et al. Depletion of resident alveolar macrophages does not prevent Fas-mediated lung injury in mice. Am J Physiol Lung Cell Mol Physiol. 2008; 295: L314-25
|
|
|
39)Redente EF, Higgins DM, Dwyer-Nield LD, et al. Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation. J Leukoc Biol. 2010; 88: 159-68
|
|
|
40)Gibbons MA, MacKinnon AC, Ramachandran P, et al. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am J Respir Crit Care Med. 2011; 184: 569-81
|
|
|
41)Kim HY, DeKruyff RH, Umetsu DT. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol. 2010; 11: 577-84
|
|
|
42)Melgert BN, ten Hacken NH, Rutgers B, et al. More alternative activation of macrophages in lungs of asthmatic patients. J Allergy Clin Immunol. 2011; 127: 831-3
|
|
|
43)Trujillo G, O’Connor EC, Kunkel SL, et al. A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis. Am J Pathol. 2008; 172: 1209-21
|
|
|
44)Reese TA, Liang HE, Tager AM, et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature. 2007; 447: 92-6
|
|
|
45)Zhu Z, Zheng T, Homer RJ, et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science. 2004; 304: 1678-82
|
|
|
46)Satoh T, Takeuchi O, Vandenbon et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol. 2010; 11: 936-44
|
|
|
47)Reece JJ, Siracusa MC, Scott AL. Innate immune responses to lung-stage helminth infection induce alternatively activated alveolar macrophages. Infect Immun. 2006; 74: 4970-81
|
|
|
48)Siracusa MC, Reece JJ, Urban JF, Jr., et al. Dynamics of lung macrophage activation in response to helminth infection. J Leukoc Biol. 2008; 84: 1422-33
|
|
|
49)Shirey KA, Pletneva LM, Puche AC, et al. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent. Mucosal Immunol. 2010; 3: 291-300
|
|
|
50)Shaykhiev R, Krause A, Salit J, et al. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol. 2009; 183: 2867-83
|
|
|
51)Woodruff PG, Koth LL, Yang YH, et al. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med. 2005; 172: 1383-92
|
|
|
52)Ather JL, Ckless K, Martin R, et al. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J Immunol. 2011; 187: 64-73
|
|
|
53)Nambu A, Nakae S. IL-1 and Allergy. Allergol Int. 2010; 59: 125-35
|
|
|
54)Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003; 3: 23-35
|
|
|
55)Kurowska-Stolarska M, Stolarski B, Kewin P, et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol. 2009; 183: 6469-77
|
|
|
56)Tsutsui H, Yoshimoto T, Hayashi N, et al. Induction of allergic inflammation by interleukin-18 in experimental animal models. Immunol Rev. 2004; 202: 115-38
|
|
|
57)Sugimoto T, Ishikawa Y, Yoshimoto T, et al. Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse. J Exp Med. 2004; 199: 535-45
|
|
|
58)Yang M, Kumar RK, Foster PS. Interferon-gamma and pulmonary macrophages contribute to the mechanisms underlying prolonged airway hyperresponsiveness. Clin Exp Allergy. 2010; 40: 163-73
|
|
|
59)Bedoret D, Wallemacq H, Marichal T, et al. Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J Clin Invest. 2009; 119: 3723-38
|
|
|
60)Holt PG, Oliver J, Bilyk N, et al. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med. 1993; 177: 397-407
|
|
|
61)Nair MG, Du Y, Perrigoue JG, et al. Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung. J Exp Med. 2009; 206: 937-52
|
|
|
62)Pesce JT, Ramalingam TR, Mentink-Kane MM, et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009; 5: e1000371
|
|
|
63)Kim EY, Battaile JT, Patel AC, et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med. 2008; 14: 633-40
|
|
|
64)Chen WH, Toapanta FR, Shirey KA, et al. Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza. Immunol Lett. 2012; 141: 227-34
|
|
|
65)Bhatia S, Fei M, Yarlagadda M, et al. Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype. PLoS One. 2011; 6: e15943
|
|
|
66)Lee CG, Hartl D, Lee GR, et al. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med. 2009; 206: 1149-66
|
|
|
67)Gregory LG, Lloyd CM. Orchestrating house dust mite-associated allergy in the lung. Trends Immunol. 2011; 32: 402-11
|
|
|
68)Dasgupta P, Keegan AD. Contribution of alternatively activated macrophages to allergic lung inflammation: a tale of mice and men. J Innate Immun. 2012; 4: 478-88
|
|
|
69)Careau E, Bissonnette EY. Adoptive transfer of alveolar macrophages abrogates bronchial hyperresponsiveness. Am J Respir Cell Mol Biol. 2004; 31: 22-7
|
|
|
70)Kradin RL, Liu HW, van Rooijen N, et al. Pulmonary immunity to Listeria is enhanced by elimination of alveolar macrophages. Am J Respir Crit Care Med. 1999; 159: 1967-74
|
|
|
71)Zaynagetdinov R, Sherrill TP, Polosukhin VV, et al. A critical role for macrophages in promotion of urethane-induced lung carcinogenesis. J Immunol. 2011; 187: 5703-11
|
|
|
72)Wang YC, He F, Feng F, et al. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer Res. 2010; 70: 4840-9
|
|
|
73)Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23: 549-55
|
|
|